GTC
Ghost Tree Capital’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-61,250
| Closed | -$77.8K | – | 55 |
|
|
2023
Q3 | $77.8K | Hold |
61,250
| – | – | 0.03% | 58 |
|
|
2023
Q2 | $202K | Buy |
+61,250
| New | +$202K | 0.07% | 54 |
|
|
2021
Q3 | – | Sell |
-450,000
| Closed | -$6.11M | – | 64 |
|
|
2021
Q2 | $6.11M | Hold |
450,000
| – | – | 1.68% | 21 |
|
|
2021
Q1 | $7.28M | Sell |
450,000
-150,000
| -25% | -$2.43M | 1.71% | 18 |
|
|
2020
Q4 | $16M | Sell |
600,000
-450,000
| -43% | -$12M | 3.56% | 9 |
|
|
2020
Q3 | $19.6M | Buy |
1,050,000
+425,000
| +68% | +$7.91M | 5.65% | 3 |
|
|
2020
Q2 | $14.6M | Sell |
625,000
-1,375,000
| -69% | -$32.2M | 3.86% | 6 |
|
|
2020
Q1 | $11.7M | Buy |
2,000,000
+1,200,000
| +150% | +$7M | 3.09% | 6 |
|
|
2019
Q4 | $4.58M | Buy |
+800,000
| New | +$4.58M | 0.87% | 30 |
|
|
2018
Q3 | – | Sell |
-600,000
| Closed | -$10.7M | – | 54 |
|
|
2018
Q2 | $10.7M | Buy |
600,000
+321,756
| +116% | +$5.75M | 3.15% | 10 |
|
|
2018
Q1 | $4.39M | Buy |
+278,244
| New | +$4.39M | 0.89% | 34 |
|